Financial Results For The Quarter Ended June 30, 2025.
Filed with BSE · · 9 pages · English
The Financial Results are also available on the website of the Company at www.venmaxdrugs.com and on the website of BSE www.bseindia.com. The Board Meeting commenced at 02:00 PM and concluded at 03:20 PM. Venkata Rao Sadhanala Whole Time Director Statement of Financial Results for the Quarter ended 30th June 2025 (RS. IN LAKHS) Notes to Accounts: 1. The above unaudited financial results of VENMAX
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 16 2025
- Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Venmax Drugs & Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 24 2025
- Board Meeting Intimation for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Equity Share Warrants.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2025
- Board Meeting Outcome for Outcome Of Board Meeting For Conversion Of Share Warrants And Allotment Of Equity Shares
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals